Literature DB >> 8667144

Development and preliminary validation of a self-report measure of psychopathic personality traits in noncriminal populations.

S O Lilienfeld1, B P Andrews.   

Abstract

Research on psychopathology has been hindered by persisting difficulties and controversies regarding its assessment. The primary goals of this set of studies were to (a) develop, and initiate the construct validation of, a self-report measure that assesses the major personality traits of psychopathy in noncriminal populations and (b) clarify the nature of these traits via an exploratory approach to test construction. This measure, the Psychopathic Personality Inventory (PPI), was developed by writing items to assess a large number of personality domains relevant to psychopathy and performing successive item-level factor analyses and revisions on three undergraduate samples. The PPI total score and its eight subscales were found to possess satisfactory internal consistency and test-retest reliability. In four studies with undergraduates, the PPI and its subscales exhibited a promising pattern of convergent and discriminant validity with self-report, psychiatric interview, observer rating, and family history data. In addition, the PPI total score demonstrated incremental validity relative to several commonly used self-report psychopathy-related measures. Future construct validation studies, unresolved conceptual issues regarding the assessment of psychopathy, and potential research uses of the PPI are outlined.

Entities:  

Mesh:

Year:  1996        PMID: 8667144     DOI: 10.1207/s15327752jpa6603_3

Source DB:  PubMed          Journal:  J Pers Assess        ISSN: 0022-3891


  176 in total

1.  The association between anxiety and psychopathy dimensions in children.

Authors:  P J Frick; S O Lilienfeld; M Ellis; B Loney; P Silverthorn
Journal:  J Abnorm Child Psychol       Date:  1999-10

2.  An item response theory integration of normal and abnormal personality scales.

Authors:  Douglas B Samuel; Leonard J Simms; Lee Anna Clark; W John Livesley; Thomas A Widiger
Journal:  Personal Disord       Date:  2010-01

3.  Emotional conditions disrupt behavioral control among individuals with dysregulated personality traits.

Authors:  Jenessa Sprague; Edelyn Verona
Journal:  J Abnorm Psychol       Date:  2010-05

4.  Genetic and environmental influences on psychopathy trait dimensions in a community sample of male twins.

Authors:  Jeanette Taylor; Bryan R Loney; Leonardo Bobadilla; William G Iacono; Matt McGue
Journal:  J Abnorm Child Psychol       Date:  2003-12

5.  Borderline personality disorder as a female phenotypic expression of psychopathy?

Authors:  Jenessa Sprague; Shabnam Javdani; Naomi Sadeh; Joseph P Newman; Edelyn Verona
Journal:  Personal Disord       Date:  2011-07-04

Review 6.  The role of prefrontal cortex in psychopathy.

Authors:  Michael Koenigs
Journal:  Rev Neurosci       Date:  2012       Impact factor: 4.353

7.  Optimizing efficiency of psychopathology assessment through quantitative modeling: development of a brief form of the Externalizing Spectrum Inventory.

Authors:  Christopher J Patrick; Mark D Kramer; Robert F Krueger; Kristian E Markon
Journal:  Psychol Assess       Date:  2013-12

8.  Clarifying the content coverage of differing psychopathy inventories through reference to the triarchic psychopathy measure.

Authors:  Laura E Drislane; Christopher J Patrick; Güler Arsal
Journal:  Psychol Assess       Date:  2013-12-09

9.  Disrupted neural processing of emotional faces in psychopathy.

Authors:  Oren Contreras-Rodríguez; Jesus Pujol; Iolanda Batalla; Ben J Harrison; Javier Bosque; Immaculada Ibern-Regàs; Rosa Hernández-Ribas; Carles Soriano-Mas; Joan Deus; Marina López-Solà; Josep Pifarré; José M Menchón; Narcís Cardoner
Journal:  Soc Cogn Affect Neurosci       Date:  2013-02-05       Impact factor: 3.436

10.  Clarifying the link between childhood abuse history and psychopathic traits in adult criminal offenders.

Authors:  Monika Dargis; Joseph Newman; Michael Koenigs
Journal:  Personal Disord       Date:  2015-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.